This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Xun Shen - Innovator in Immunoassay Technology
Introduction
Xun Shen is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of immunoassays, particularly in the measurement of circulating PCSK9 levels. His work is crucial for advancing medical diagnostics and therapeutic strategies.
Latest Patents
Xun Shen holds a patent for a method titled "PCSK9 immunoassay - Methods of using PCSK9 antagonists." This patent focuses on innovative techniques for measuring PCSK9 levels in biological samples through an immunoassay. The methods described include the use of solid phase immunoassays, specifically a dissociation-enhanced lanthanide fluorescence immunoassay that utilizes an E07 capture antibody and a G08 or H23 detecting antibody. He has 1 patent to his name.
Career Highlights
Xun Shen is currently employed at Merck Sharp & Dohme Corp., where he continues to develop and refine his innovative techniques. His work has implications for understanding cholesterol metabolism and cardiovascular health.
Collaborations
Xun Shen collaborates with esteemed colleagues, including Timothy McCabe and Yan Ni. Their combined expertise enhances the research and development efforts within their field.
Conclusion
Xun Shen's contributions to immunoassay technology exemplify the impact of innovative thinking in the medical field. His work not only advances scientific knowledge but also holds promise for improving patient care.